19 June 2013
Keywords: analysts, opinions, differ, over, future, prospects, medimmune
Article | 05 October 2000
MedImmune's share price has taken a hefty tumble, amid a difference ofopinion among industry observers about the effect that slowing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 June 2000
14 June 2000
18 June 2013
© 2013 thepharmaletter.com